Serological responses to SARS-CoV-2 vaccination
1 paper studies it1 finding
- Humans1
Upstream
1PLCG2
no changein humans1
1 study
PLCG2
no changein humans1
PLCG2 has no effect on serological responses to SARS-CoV-2 vaccination in humans.
“Nevertheless, carriers and non-carriers had similar serological responses to SARS-CoV-2 vaccination.”
Humans
Carriers of the p.P522R variant in PLCγ2 have a slightly more responsive immune system
Molecular neurodegeneration
Latest
Molecular Neurodegeneration
Carriers of the p.P522R variant in PLCγ2 have a slightly more responsive immune system
Cohort study in peopleImmune response